Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
---|---|---|---|---|
ORBIMED ADVISORS LLC | 05-16-2022 | 03-31-2022 | 145 | 6,167,262,000 |
Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
---|---|---|---|---|---|---|---|---|---|
GILEAD SCIENCES INC | COM | 101 | $17,098,000 | 287,600 | 0.28 | 0.20 | 0 | 0.00 | 03-31-2022 |
UNIQURE NV | SHS | 102 | $16,611,000 | 919,249 | 0.27 | 0.15 | 448,075 | 95.10 | 03-31-2022 |
MILESTONE PHARMACEUTICALS IN | COM | 103 | $16,588,000 | 2,583,821 | 0.27 | 0.14 | 0 | 0.00 | 03-31-2022 |
ULTRAGENYX PHARMACEUTICAL IN | COM | 104 | $16,528,000 | 227,600 | 0.27 | 227,600 | +Inf | 03-31-2022 |